Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

PPBT holding history

Purple Biotech Ltd. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PPBT overviewAll 13F holders of PPBTFull Q2 2026 holdings

Shares (Q2 2026)
751
Value
$1.26K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of PPBT by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026751$1.26K<0.1%+652+658.6%AddedHolders
Q1 202699$400<0.1%−2,999−96.8%ReducedHolders
Q4 20253,098$2.04K<0.1%−2,849−47.9%ReducedHolders
Q3 20255,947$3.41K<0.1%−17,197−74.3%ReducedHolders
Q2 202523,144$54.3K<0.1%+119+0.5%AddedHolders
Q1 202523,025$61.2K<0.1%+12,242+113.5%AddedHolders
Q4 202410,783$50.6K<0.1%+10,783NewHolders
Q3 20240$00.0%−643−100.0%Sold outConverted for a 1-for-20 splitHolders
Q2 202412,852$5.23K<0.1%+1,241+10.7%AddedHolders
Q1 202411,611$7.78K<0.1%+9,611+480.6%AddedHolders
Q4 20232,000$1.56K<0.1%+133+7.1%AddedHolders
Q3 20231,867$2.22K<0.1%+1,867NewHolders
Q2 20230$00.0%−4,566−100.0%Sold outHolders
Q1 20234,566$8.17K<0.1%−3,723−44.9%ReducedHolders
Q4 20228,289$11.4K<0.1%−2,239−21.3%ReducedHolders
Q3 202210,528$21.0K<0.1%+5,868+125.9%AddedHolders
Q2 20224,660$11.0K<0.1%+2,658+132.8%AddedHolders
Q1 20222,002$8.00K<0.1%−1,066−34.7%ReducedHolders
Q4 20213,068$12.0K<0.1%−1,011−24.8%ReducedHolders
Q3 20214,079$19.0K<0.1%−17,090−80.7%ReducedHolders
Q2 202121,169$104.0K<0.1%+2,994+16.5%AddedHolders
Q1 202118,175$75.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.